Citadel Advisors’s Astera Labs ALAB Stock Holding History

Citadel Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-302,531	Closed	-$80.3M	–	15056
2026 Q1	$33.2M	Buy	302,531 +179,486	+146%	+$25.6M	0.01%	1755
2025 Q4	$20.5M	Sell	123,045 -203,448	-62%	-$34M	﹤0.01%	2309
2025 Q3	$63.9M	Buy	326,493 +290,126	+798%	+$47.7M	0.01%	1166
2025 Q2	$3.29M	Sell	36,367 -346,085	-90%	-$27.3M	﹤0.01%	4826
2025 Q1	$22.8M	Buy	382,452 +271,702	+245%	+$25.1M	﹤0.01%	1894
2024 Q4	$14.7M	Sell	110,750 -688,298	-86%	-$64.6M	﹤0.01%	2520
2024 Q3	$41.9M	Buy	+799,048	New	+$37.5M	0.01%	1383
2024 Q2	–	Sell	-623,000	Closed	-$43.2M	–	15611
2024 Q1	$46.2M	Buy	+623,000	New	+$46.2M	0.01%	1274

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors's ALAB Position: Q2 2026 in Review

Citadel Advisors sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 302,531 shares — an estimated $80.3M sold.

Citadel Advisors first reported a position in ALAB in Q1 2024 and held it in 8 quarters. The position peaked at $63.9M in Q3 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Citadel Advisors reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 302,531 Astera Labs shares in Q2 2026, an estimated $80.3M.
Citadel Advisors first reported a position in Astera Labs in Q1 2024 and held it in 8 quarters.
Citadel Advisors's Astera Labs position peaked at $63.9M in Q3 2025.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.